PBS Datasets
Collection
A collection of datasets from the Australian Pharmaceutical Benefits Scheme (PBS). Updated with a new schedule on the 1st of every month.
•
32 items
•
Updated
Dataset Viewer
atc_code
stringlengths 1
7
| atc_description
stringlengths 3
113
| atc_level
int64 1
5
| atc_parent_code
stringlengths 1
5
⌀ | schedule_code
int64 3.67k
3.67k
|
|---|---|---|---|---|
A
|
ALIMENTARY TRACT AND METABOLISM
| 1 | null | 3,671 |
A00
|
ALIMENTARY TRACT AND METABOLISM
| 2 |
A
| 3,671 |
A01
|
STOMATOLOGICAL PREPARATIONS
| 2 |
A
| 3,671 |
A01A
|
STOMATOLOGICAL PREPARATIONS
| 3 |
A01
| 3,671 |
A01AA
|
Caries prophylactic agents
| 4 |
A01A
| 3,671 |
A01AA01
|
sodium fluoride
| 5 |
A01AA
| 3,671 |
A01AA02
|
sodium monofluorophosphate
| 5 |
A01AA
| 3,671 |
A01AA03
|
olaflur
| 5 |
A01AA
| 3,671 |
A01AA04
|
stannous fluoride
| 5 |
A01AA
| 3,671 |
A01AA30
|
combinations
| 5 |
A01AA
| 3,671 |
A01AA51
|
sodium fluoride, combinations
| 5 |
A01AA
| 3,671 |
A01AB
|
Antiinfectives and antiseptics for local oral treatment
| 4 |
A01A
| 3,671 |
A01AB02
|
hydrogen peroxide
| 5 |
A01AB
| 3,671 |
A01AB03
|
chlorhexidine
| 5 |
A01AB
| 3,671 |
A01AB04
|
amphotericin B
| 5 |
A01AB
| 3,671 |
A01AB05
|
polynoxylin
| 5 |
A01AB
| 3,671 |
A01AB06
|
domiphen
| 5 |
A01AB
| 3,671 |
A01AB07
|
oxyquinoline
| 5 |
A01AB
| 3,671 |
A01AB08
|
neomycin
| 5 |
A01AB
| 3,671 |
A01AB09
|
miconazole
| 5 |
A01AB
| 3,671 |
A01AB10
|
natamycin
| 5 |
A01AB
| 3,671 |
A01AB11
|
various
| 5 |
A01AB
| 3,671 |
A01AB12
|
hexetidine
| 5 |
A01AB
| 3,671 |
A01AB13
|
tetracycline
| 5 |
A01AB
| 3,671 |
A01AB14
|
benzoxonium chloride
| 5 |
A01AB
| 3,671 |
A01AB15
|
tibezonium iodide
| 5 |
A01AB
| 3,671 |
A01AB16
|
mepartricin
| 5 |
A01AB
| 3,671 |
A01AB17
|
metronidazole
| 5 |
A01AB
| 3,671 |
A01AB18
|
clotrimazole
| 5 |
A01AB
| 3,671 |
A01AB19
|
sodium perborate
| 5 |
A01AB
| 3,671 |
A01AB21
|
chlortetracycline
| 5 |
A01AB
| 3,671 |
A01AB22
|
doxycycline
| 5 |
A01AB
| 3,671 |
A01AB23
|
minocycline
| 5 |
A01AB
| 3,671 |
A01AB24
|
octenidine
| 5 |
A01AB
| 3,671 |
A01AB25
|
oxytetracycline
| 5 |
A01AB
| 3,671 |
A01AB53
|
chlorhexidine and cetylpyridinium
| 5 |
A01AB
| 3,671 |
A01AC
|
Corticosteroids for local oral treatment
| 4 |
A01A
| 3,671 |
A01AC01
|
triamcinolone
| 5 |
A01AC
| 3,671 |
A01AC02
|
dexamethasone
| 5 |
A01AC
| 3,671 |
A01AC03
|
hydrocortisone
| 5 |
A01AC
| 3,671 |
A01AC04
|
prednisolone
| 5 |
A01AC
| 3,671 |
A01AC54
|
prednisolone, combinations
| 5 |
A01AC
| 3,671 |
A01AD
|
Other agents for local oral treatment
| 4 |
A01A
| 3,671 |
A01AD01
|
epinephrine
| 5 |
A01AD
| 3,671 |
A01AD02
|
benzydamine
| 5 |
A01AD
| 3,671 |
A01AD05
|
acetylsalicylic acid
| 5 |
A01AD
| 3,671 |
A01AD06
|
adrenalone
| 5 |
A01AD
| 3,671 |
A01AD07
|
amlexanox
| 5 |
A01AD
| 3,671 |
A01AD08
|
becaplermin
| 5 |
A01AD
| 3,671 |
A01AD11
|
various
| 5 |
A01AD
| 3,671 |
A02
|
DRUGS FOR ACID RELATED DISORDERS
| 2 |
A
| 3,671 |
A02A
|
ANTACIDS
| 3 |
A02
| 3,671 |
A02AA
|
Magnesium compounds
| 4 |
A02A
| 3,671 |
A02AA01
|
magnesium carbonate
| 5 |
A02AA
| 3,671 |
A02AA02
|
magnesium oxide
| 5 |
A02AA
| 3,671 |
A02AA03
|
magnesium peroxide
| 5 |
A02AA
| 3,671 |
A02AA04
|
magnesium hydroxide
| 5 |
A02AA
| 3,671 |
A02AA05
|
magnesium silicate
| 5 |
A02AA
| 3,671 |
A02AA10
|
combinations
| 5 |
A02AA
| 3,671 |
A02AB
|
Aluminium compounds
| 4 |
A02A
| 3,671 |
A02AB01
|
aluminium hydroxide
| 5 |
A02AB
| 3,671 |
A02AB02
|
algeldrate
| 5 |
A02AB
| 3,671 |
A02AB03
|
aluminium phosphate
| 5 |
A02AB
| 3,671 |
A02AB04
|
dihydroxialumini sodium carbonate
| 5 |
A02AB
| 3,671 |
A02AB05
|
aluminium acetoacetate
| 5 |
A02AB
| 3,671 |
A02AB06
|
aloglutamol
| 5 |
A02AB
| 3,671 |
A02AB07
|
aluminium glycinate
| 5 |
A02AB
| 3,671 |
A02AB10
|
combinations
| 5 |
A02AB
| 3,671 |
A02AC
|
Calcium compounds
| 4 |
A02A
| 3,671 |
A02AC01
|
calcium carbonate
| 5 |
A02AC
| 3,671 |
A02AC02
|
calcium silicate
| 5 |
A02AC
| 3,671 |
A02AC10
|
combinations
| 5 |
A02AC
| 3,671 |
A02AD
|
Combinations and complexes of aluminium, calcium and magnesium compounds
| 4 |
A02A
| 3,671 |
A02AD01
|
ordinary salt combinations
| 5 |
A02AD
| 3,671 |
A02AD02
|
magaldrate
| 5 |
A02AD
| 3,671 |
A02AD03
|
almagate
| 5 |
A02AD
| 3,671 |
A02AD04
|
hydrotalcite
| 5 |
A02AD
| 3,671 |
A02AD05
|
almasilate
| 5 |
A02AD
| 3,671 |
A02AF
|
Antacids with antiflatulents
| 4 |
A02A
| 3,671 |
A02AF01
|
magaldrate and antiflatulents
| 5 |
A02AF
| 3,671 |
A02AF02
|
ordinary salt combinations and antiflatulents
| 5 |
A02AF
| 3,671 |
A02AG
|
Antacids with antispasmodics
| 4 |
A02A
| 3,671 |
A02AH
|
Antacids with sodium bicarbonate
| 4 |
A02A
| 3,671 |
A02AX
|
Antacids, other combinations
| 4 |
A02A
| 3,671 |
A02B
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
| 3 |
A02
| 3,671 |
A02BA
|
H2-receptor antagonists
| 4 |
A02B
| 3,671 |
A02BA01
|
cimetidine
| 5 |
A02BA
| 3,671 |
A02BA02
|
ranitidine
| 5 |
A02BA
| 3,671 |
A02BA03
|
famotidine
| 5 |
A02BA
| 3,671 |
A02BA04
|
nizatidine
| 5 |
A02BA
| 3,671 |
A02BA05
|
niperotidine
| 5 |
A02BA
| 3,671 |
A02BA06
|
roxatidine
| 5 |
A02BA
| 3,671 |
A02BA07
|
ranitidine bismuth citrate
| 5 |
A02BA
| 3,671 |
A02BA08
|
lafutidine
| 5 |
A02BA
| 3,671 |
A02BA51
|
cimetidine, combinations
| 5 |
A02BA
| 3,671 |
A02BA53
|
famotidine, combinations
| 5 |
A02BA
| 3,671 |
A02BB
|
Prostaglandins
| 4 |
A02B
| 3,671 |
A02BB01
|
misoprostol
| 5 |
A02BB
| 3,671 |
A02BB02
|
enprostil
| 5 |
A02BB
| 3,671 |
A02BC
|
Proton pump inhibitors
| 4 |
A02B
| 3,671 |
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 62
Size of downloaded dataset files:
487 kB
Size of the auto-converted Parquet files:
487 kB
Number of rows:
23,364